AI Scribe for Primary-Care Docs: Notewell’s 480‑Day Journey to $30M Exit
Notewell built an AI scribe for primary‑care doctors, grew to $573k MRR in 480 days, navigated churn, cash crunch, and strategic decisions before selling for $30.9M.
- Idea: AI scribe for primary-care doctors that writes the clinical note and billing codes straight into the health record
- Result: Sold for $30.9M on day 480
- Peak MRR: $575.1k
- Final MRR: $573.7k · 5680 customers · team of 50
Early Traction and First Revenue
Notewell landed its first doctor on day 44 and hit $1,000 MRR by day 54. The product reached $10,000 MRR on day 113 and $50,000 MRR on day 201, showing a steady climb despite a cash low of $500 on day 14. By day 480 the company was pulling in $573,680 MRR from 5,680 customers, with cash sitting at $577,017. Early sales were driven by a high‑volume cold‑email engine (7,107 rounds) and 2,803 sales calls, converting 7,783 leads into paying users.
Feature Velocity and Market Expansion
The team shipped 62 features across 480 days, including a dashboard, SSO, mobile app, and a public REST API. Major releases such as the Mid‑market edition, Enterprise plan, Platform rewrite, and regional launches in Europe and APAC were timed between days 290 and 431. These upgrades supported a progressive‑web app strategy and an AI assistant, keeping the product competitive and enabling the jump to the $573k MRR peak.
Operational Headwinds and Tactical Choices
Monthly churn averaged 7.14%, costing 366 customers in month 16. That month also recorded a $390,750 burn, but a net positive of $182,930 helped the cash runway. The founders faced a series of decisions: they accepted seed deals on days 323 and 395 for 20% equity, passed on two angel meetings, matched a competitor’s price quietly, and ran a $600 newsletter ad. When a critical dependency vulnerability surfaced on day 471 they patched it on the next cycle, and they spent $700 on ads after a trending space event on day 448.
Exit and Takeaways
After 480 days, a 50‑person team sold Notewell for $30,901,605. The exit reflected the value of a high‑touch sales organization (15 salespeople) and a robust feature set that addressed both primary‑care and enterprise needs. The company’s journey highlighted how disciplined feature releases, careful cash management, and selective investor engagement can turn a promising AI health‑tech idea into a multi‑million‑dollar acquisition.
Lessons
- Validate early product‑market fit quickly; the first paying doctor arrived within six weeks.
- Balance rapid feature delivery with technical debt; an emergency refactor on day 349 prevented longer‑term velocity loss.
- Use data‑driven decisions on pricing and churn mitigation; matching a competitor’s price and personal outreach to failing subscriptions limited revenue leakage.